Impact of Prehospital Ticagrelor Loading Dose Combined With Aspirin Dual Antiplatelet Therapy on Post-PCI TIMI Flow Grade in Patients With ST-Elevation Myocardial Infarction [0.03%]
院前替格瑞洛联合阿司匹林双联抗血小板治疗对ST段抬高型心肌梗死患者急诊PCI术后TIMI血流分级的影响
Pingwei Liu,Guangsheng Cai,Yanmei Wang et al.
Pingwei Liu et al.
Background: Early dual antiplatelet therapy (DAPT) improves outcomes in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). Although guidelines recommend prompt...
Explanatory Variables of Objectively Measured 24 h Movement Behaviors in Coronary Heart Disease Patients: A Systematic Review [0.03%]
冠心病患者客观测量的24小时运动行为的解释变量:系统性综述
Xiaofeng Peng,Ting Guo,Xiuzheng Wang et al.
Xiaofeng Peng et al.
Aims: This study systematically examined the multilevel determinants influencing 24 h movement behaviors (physical activity, sedentary behavior, and sleep) in coronary heart disease patients on the basis of a socioecologi...
Comment on "Mortality Related to Different Circulatory Diseases Before, During and After the COVID-19 Pandemic" [0.03%]
对新冠肺炎大流行前、期间和之后不同循环系统疾病相关死亡率的点评
Abhinit Kumar,Ranjana Roy,Parappa Sajjan et al.
Abhinit Kumar et al.
Temporal Trends in Mortality Due to Ischemic Heart Disease and Cardiac Arrhythmias in the United States From 1999 to 2023 [0.03%]
1999年至2023年美国缺血性心脏病和心律失常死亡率的时空趋势分析
Taha Alam,Sohaima Kamal,Dhvanit Rajdeep et al.
Taha Alam et al.
Background: Ischemic heart disease (IHD) remains a leading cause of mortality in the United States, while arrhythmia-related deaths are increasing. However, long-term mortality trends involving both conditions remain uncl...
Dynamic Urinary Albumin/Creatinine Ratio Patterns Predict Adverse Outcomes in HFpEF: TOPCAT Cohort Analysis [0.03%]
尿微量白蛋白/肌酐比值动态变化可预测HFpEF患者预后:TOPCAT队列分析
Weiping Xiao,Zhiyan Wang,Di-En Yan et al.
Weiping Xiao et al.
Background: Urinary albumin-to-creatinine ratio (uACR) is a recognized cardiovascular risk marker, but its dynamic changes in heart failure with preserved ejection fraction (HFpEF) remain underexplored. We aimed to identi...
Randomized Controlled Trial
Clinical cardiology. 2026 Aug;49(8):e70446. DOI:10.1002/clc.70446 2026
Dynamic Urinary Albumin/Creatinine Ratio Patterns Predict Adverse Outcomes in HFpEF: TOPCAT Cohort Analysis [0.03%]
动态尿微量白蛋白/肌酐比值模式可预测HFpEF患者的不良预后:TOPCAT队列分析
Weiping Xiao,Zhiyan Wang,Di-En Yan et al.
Weiping Xiao et al.
Background: Urinary albumin-to-creatinine ratio (uACR) is a recognized cardiovascular risk marker, but its dynamic changes in heart failure with preserved ejection fraction (HFpEF) remain underexplored. We aimed to identi...
Randomized Controlled Trial
Clinical cardiology. 2026 Aug;49(8):e70446. DOI:10.1002/clc.70446 2026
Dynamic Urinary Albumin/Creatinine Ratio Patterns Predict Adverse Outcomes in HFpEF: TOPCAT Cohort Analysis [0.03%]
动态尿白蛋白/肌酐比值模式可预测HFpEF患者的不良结局:TOPCAT队列分析
Weiping Xiao,Zhiyan Wang,Di-En Yan et al.
Weiping Xiao et al.
Background: Urinary albumin-to-creatinine ratio (uACR) is a recognized cardiovascular risk marker, but its dynamic changes in heart failure with preserved ejection fraction (HFpEF) remain underexplored. We aimed to identi...
Randomized Controlled Trial
Clinical cardiology. 2026 Aug;49(8):e70446. DOI:10.1002/clc.70446 2026
Superior Cardiorenal Protection With Tirzepatide Over Dulaglutide in Heart Failure With Preserved Ejection Fraction: A Large-Scale Propensity Score-Matched Real-World Analysis [0.03%]
替扎パタ德相对于杜拉肽在射血分数保留的心力衰竭中的优效性:大规模倾向性匹配的真实世界分析
Ibrahim Khalil,Md Imran Hossain,Mst Mahmuda Akter et al.
Ibrahim Khalil et al.
Background: No direct head-to-head trials compare tirzepatide and dulaglutide in heart failure with preserved ejection fraction (HFpEF), though tirzepatide shows superior weight loss and potential cardiovascular benefits ...
Multicenter Study
Clinical cardiology. 2026 Aug;49(8):e70441. DOI:10.1002/clc.70441 2026
Superior Cardiorenal Protection With Tirzepatide Over Dulaglutide in Heart Failure With Preserved Ejection Fraction: A Large-Scale Propensity Score-Matched Real-World Analysis [0.03%]
与心力衰竭射血分数保留患者中的度拉吉肽相比, tirzepatide 对心脏和肾脏有更好的保护作用:一项大规模倾向性匹配的现实世界分析
Ibrahim Khalil,Md Imran Hossain,Mst Mahmuda Akter et al.
Ibrahim Khalil et al.
Background: No direct head-to-head trials compare tirzepatide and dulaglutide in heart failure with preserved ejection fraction (HFpEF), though tirzepatide shows superior weight loss and potential cardiovascular benefits ...
Multicenter Study
Clinical cardiology. 2026 Aug;49(8):e70441. DOI:10.1002/clc.70441 2026
Correction to "Trends and Disparities in Acute Myocardial Infarction-Related Mortality With Co-Listed Nicotine Dependence in the United States, 1999-2020" [0.03%]
对“美国1999-2020年急性心肌梗死相关死亡率与列出的尼古丁依赖症差异的趋势及不平等现象”的勘误通知
Published Erratum
Clinical cardiology. 2026 Aug;49(8):e70432. DOI:10.1002/clc.70432 2026